Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Pasadena, California
- Most recent report
- 10-Q, filed Nov 4, 2026
- Incorporated
- Delaware
- Filings on record
- 897 filings
- On EDGAR
- CIK 1326732
- Fiscal year ends
- December
- Filer status
- Accelerated filer
Financials 8 of 57
News 8 of 137
Prospectuses and Registrations 8 of 31
- S-8 Registration statement for an employee plan Feb 25, 2026
- S-3ASR Automatic shelf registration Feb 25, 2026
- 424B5 Prospectus supplement for an offering Sep 12, 2024
- 424B5 Prospectus supplement for an offering Sep 10, 2024
- S-8 Registration statement for an employee plan Jun 16, 2023
- S-8 POS Post-effective amendment to an employee plan registration Jun 16, 2023
- S-8 POS Post-effective amendment to an employee plan registration Jun 16, 2023
- S-8 POS Post-effective amendment to an employee plan registration Jun 16, 2023
Proxies 8 of 26
- DEFA14A Extra proxy material Apr 27, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 27, 2026
- DEFA14A Extra proxy material Apr 23, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 23, 2025
- DEFA14A Extra proxy material Apr 24, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 24, 2024
- DEFR14A May 1, 2023
- DEFA14A Extra proxy material Apr 26, 2023
Ownership 8 of 597
- SCHEDULE 13G/A Large holder reported a passive stake, amended Nov 6, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Nov 5, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Oct 30, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Oct 27, 2026
- SCHEDULE 13G Large holder reported a passive stake Jul 31, 2026
- 4 Insider reported a trade Jul 8, 2026
- 4 Insider reported a trade Jul 8, 2026
- 4 Insider reported a trade Jul 8, 2026
Other 8 of 49
Everything here comes from Xencor Inc's own filings on SEC EDGAR. The filing list is rechecked every hour.